Value Sense
PODD
Insulet Corporation (PODD)
Last Price$272.70.1%
Market Cap$19.4B
LTM Dividend per Share (DPS)
$0.0
5Y avg
$0.0
Medical - Devices industry median
$0.0
Stock quality & Intrinsic value
8/10
(0.5%) overvalued
PODD
is (50.7%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Insulet Corporation Dividend per Share (DPS)

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Dividend per Share (DPS)
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
PODD
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for PODD and see if it's the right time to invest.
Dive in

Insulet Corporation (PODD) Dividend per Share (DPS) comparison analysis

General

LTM Dividend per Share (DPS)

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Insulet Corporation logo
Insulet CorporationPODD
$0.0
30.0%
4,364.6%
12.2%
Median Peer Set
$0.5
4.1%
72.0%
12.4%
Stryker Corporation logo
Stryker CorporationSYK
$3.2
10.2%
(5.8%)
13.2%
Medtronic plc logo
Medtronic plcMDT
$2.8
3.6%
(2.1%)
11.4%
Abbott Laboratories logo
Abbott LaboratoriesABT
$2.2
4.6%
134.5%
31.9%
STERIS plc logo
STERIS plcSTE
$2.2
3.6%
257.9%
7.4%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
$1.0
6.5%
253.2%
13.8%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
$0.0
17.6%
16.7%
11.1%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
$0.0
(9.4%)
202.2%
76.7%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
$0.0
(0.8%)
118.1%
(3.9%)
DexCom, Inc. logo
DexCom, Inc.DXCM
$0.0
11.3%
(1.4%)
14.3%
Align Technology, Inc. logo
Align Technology, Inc.ALGN
$0.0
3.4%
26.0%
11.5%

PODD key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
0.0
0.0%
0.1
0.0%
3.7
7,226.0%
13.4
265.1%
36.1
169.7%
66.0
83.1%
97.0
46.8%
152.3
57.0%
211.4
38.8%
247.1
16.9%
288.7
16.9%
263.9
(8.6%)
367.0
39.1%
463.8
26.4%
563.8
21.6%
738.2
30.9%
904.4
22.5%
1,098.8
21.5%
1,305.3
18.8%
1,697.1
30.0%
Cost of Goods Sold (COGS)0.01.515.725.740.647.753.285.5119.0134.7145.4130.6155.9186.6193.7257.9322.1346.7499.7537.2
Gross Profit
% margin
0.0
0.0%
(1.5)
(2,960.0%)
(12.0)
(327.5%)
(12.4)
(92.4%)
(4.6)
(12.7%)
18.3
27.7%
43.7
45.1%
66.7
43.8%
92.3
43.7%
112.4
45.5%
143.3
49.6%
133.3
50.5%
211.1
57.5%
277.2
59.8%
370.2
65.7%
480.3
65.1%
582.3
64.4%
752.1
68.4%
805.6
61.7%
1,159.9
68.3%
Operating Expenses14.220.022.641.584.877.777.9109.2128.3141.5155.6182.0221.8284.6342.7430.3530.8626.1768.0939.9
Research & Development Expenses (R&D)9.010.88.110.413.113.216.621.924.421.827.943.255.774.588.6129.7146.8160.1180.2205.0
Selling, General & Administrative Expenses (SG&A)5.19.314.630.163.564.461.487.3103.9119.8127.7138.8166.1210.1254.1300.6384.0466.0587.8734.9
Operating Income
% margin
(14.2)
0.0%
(21.5)
(43,010.0%)
(34.6)
(945.8%)
(53.8)
(402.6%)
(89.3)
(247.8%)
(59.4)
(89.9%)
(38.6)
(39.8%)
(42.5)
(27.9%)
(36.0)
(17.0%)
(29.1)
(11.8%)
(12.3)
(4.3%)
(48.7)
(18.5%)
(10.7)
(2.9%)
(7.4)
(1.6%)
27.4
4.9%
22.1
3.0%
(0.6)
(0.1%)
66.7
6.1%
(26.7)
(2.0%)
220.0
13.0%
Interest Income0.00.00.00.01.80.20.20.10.10.10.10.10.82.66.77.83.00.59.828.6
Interest Expense0.00.00.00.07.220.222.714.715.817.214.712.714.419.222.226.845.161.226.736.2
Pre-tax Income0.00.0(35.5)(53.5)(92.8)(79.5)(61.2)(57.0)(51.7)(44.9)(51.4)(61.4)(26.8)(26.6)5.214.59.720.59.8214.6
Income Tax
% effective tax rate
(0.3)
0.0%
0.1
0.0%
1.3
(3.7%)
(0.3)
0.6%
3.4
(3.7%)
(5.2)
6.6%
21.9
(35.8%)
0.1
(0.2%)
0.2
(0.4%)
0.1
(0.2%)
0.1
(0.3%)
0.2
(0.3%)
0.4
(1.5%)
0.3
(1.0%)
1.9
37.0%
2.9
20.0%
2.9
29.9%
3.7
18.0%
5.2
53.1%
8.3
3.9%
Net Income
% margin
(13.8)
0.0%
(21.6)
(43,272.0%)
(36.0)
(981.4%)
(53.5)
(400.4%)
(92.8)
(257.3%)
(79.5)
(120.5%)
(61.2)
(63.1%)
(57.2)
(37.5%)
(51.9)
(24.5%)
(45.0)
(18.2%)
(51.5)
(17.8%)
(73.5)
(27.9%)
(28.9)
(7.9%)
(26.8)
(5.8%)
3.3
0.6%
11.6
1.6%
6.8
0.8%
16.8
1.5%
4.6
0.4%
206.3
12.2%
EPS(47.64)(70.95)(99.10)(3.21)(3.36)(2.68)(1.54)(1.22)(1.08)(0.83)(0.93)(1.29)(0.51)(0.46)0.060.190.110.250.072.96
Diluted EPS(47.64)(70.95)(39.19)(3.21)(3.36)(2.68)(1.54)(1.22)(1.08)(0.83)(0.93)(1.29)(0.50)(0.46)0.050.190.100.250.072.80
EBITDA
% margin
(13.5)
0.0%
(20.3)
(40,538.0%)
(32.0)
(873.7%)
(48.9)
(365.9%)
(81.2)
(225.1%)
(53.9)
(81.6%)
(33.4)
(34.4%)
(35.8)
(23.5%)
(24.8)
(11.7%)
(16.2)
(6.5%)
(24.4)
(8.5%)
(36.3)
(13.7%)
1.3
0.3%
6.5
1.4%
49.8
8.8%
77.0
10.4%
110.3
12.2%
139.6
12.7%
109.5
8.4%
323.6
19.1%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Insulet Corporation's Dividend per Share (DPS)?

As of today, Insulet Corporation's last 12-month Dividend per Share (DPS) is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Insulet Corporation's Dividend per Share (DPS) growth rate?

Over the last year, Insulet Corporation's Dividend per Share (DPS) growth was N/A. The average annual Dividend per Share (DPS) growth rates for Insulet Corporation have been N/A over the past three years, N/A over the past five years.